Trial Profile
Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 for Hyperuricemia With or Without Gout to Evaluate the Safety and Noninferiority of FYU-981 (Phase III Study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Nov 2021
Price :
$35
*
At a glance
- Drugs Dotinurad (Primary) ; Benzbromarone
- Indications Hyperuricaemia
- Focus Therapeutic Use
- Sponsors Fuji Yakuhin
- 15 Nov 2021 Results of systematic review and meta-analysis of randomized controlled trials (NCT02416167, NCT03100318, NCT03372200 ) were published in the International Journal of Clinical Pharmacology and Therapeutics.
- 24 Sep 2018 Status changed from active, no longer recruiting to completed.
- 07 Sep 2017 Status changed from recruiting to active, no longer recruiting.